Akorn Sharpens Focus As It Divests Ophthalmic Brands

Focusing On Human Generics And Animal Care After Completing Sale To Théa Pharma

 
• By David Wallace
  
Glasses Eye Test Chart Vision Focus
Akorn is sharpening the focus of its business with the divestment of its ophthalmic brands • Source: David Izquierdo Roger / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business